News
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...
The "Laboratory Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global Laboratory Supplies ...
Currently in the process of expanding its offices, Tegan Innovations is a showcase for Waterford’s highly skilled workforce ...
Q1 2025 Management View CEO Eric Green highlighted that the company exceeded expectations for revenues and adjusted EPS in Q1 ...
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.
The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.
StockStory.org on MSN1d
West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock SoarsHealthcare products company West Pharmaceutical Services (NYSE:WST) announced in Q1 CY2025, but sales were flat year on year ...
As the pharmaceutical industry continues to evolve with increasing regulatory expectations, this success story provides ...
West Pharmaceutical Servs WST is preparing to release its quarterly earnings on Thursday, 2025-04-24. Here's a brief overview ...
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results